Trademarkia Logo

Australia

AU$
CINCOR
Cancelled: Cancelled at the request of IB

Last updated on 28 May 2024

Owner Info

Cincor Pharma, Inc.

230 Third Avenue, 6th Floor

Waltham MA 02451, UNITED STATES OF AMERICA

Serial Number

2258485 filed on 3 Dec 2021

Correspondent

Kevin M. Bovard, Baker & Hostetler LLP

1735 Market Street,,

Suite 3300,

UNITED STATES OF AMERICA

CINCOR

Classification Information


Class [005]
Pharmaceuticals, namely, aldosterone synthase inhibitors for treatment of primary aldosteronism, hypertension, kidney disease, liver disease, heart fa Read More

Mark Details


Serial Number

2258485

Registered On

7 Mar 2022

Renewal On

NA

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
28th May 2024Status change to Voided
2th Feb 2023Amendment to International Registration Contact Requested
18th Oct 2022International Registration in Australia Protected correspondence sent
17th Oct 2022IP Right Registration Published
17th Oct 2022Status change to Registered/Protected
6th Oct 2022Amendment to Amend Owner Requested
8th Aug 2022Application Accepted correspondence sent
8th Aug 2022IP Right has been Examined
8th Aug 2022IP Right Acceptance Published
11th Apr 2022Status change to Accepted